Vote Scores
Filings read through

Catalyst Pharmaceuticals, Inc.: how funds voted at the meeting of 22 Aug 2023

Meeting
Season
year to 30 June 2024
Filers reporting
387
Ballot items
7

387 filers on Form N-PX reported votes at the Catalyst Pharmaceuticals, Inc. meeting of 22 Aug 2023. The records fall into 7 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Catalyst Pharmaceuticals, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    7 nominees. 95.4% of the reported votes are for. 28 filers withheld from or voted against at least one nominee.

    2,058 vote records from 151 filers. 6 of the 151 filers that marked the item voted against management.

    • Positions of 43 fund families
    • For 42
    • Against 1
    • Against management 1
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    648 vote records from 379 filers. 28 of the 366 filers that marked the item voted against management. 13 filers gave no management mark.

    4 filers reported share counts too large for the holding. The site publishes no share split for this item. The rule

    • Positions of 48 fund families
    • For 46
    • Against 2
    • Against management 2
  3. Item 3: Audit-related items (auditor ratification)

    293 vote records from 150 filers. 1 of the 150 filers that marked the item voted against management.

    • Positions of 43 fund families
    • For 43
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    318 vote records from 155 filers. 7 of the 155 filers that marked the item voted against management.

    • Positions of 43 fund families
    • For 41
    • Against 2
    • Against management 2
  5. Item 5: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    266 vote records from 136 filers. 134 of the 136 filers that marked the item voted against management.

    • Positions of 40 fund families
    • Against 40
    • Against management 40
  6. Item 6: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    28 vote records from 17 filers. 13 of the 17 filers that marked the item voted against management.

    • Positions of 4 fund families
    • For 2
    • Against 2
    • Against management 2
  7. Item 7: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    1 vote record from 1 filer. 0 of the 1 filer that marked the item voted against management.

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Catalyst Pharmaceuticals, Inc., meeting of 22 Aug 2023Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinForFor
AllspringForFor
American CenturyForFor
BairdForNo report
BlackRock and iSharesForFor
BNY MellonForFor
Brighthouse FundsForFor
Charles SchwabForFor
Columbia ThreadneedleAgainst, against managementFor
DimensionalForFor
DWSForFor
EquitableForFor
Federated HermesForFor
FidelityForFor
First TrustForFor
Franklin TempletonForFor
Goldman SachsForFor
Guggenheim and RydexForFor
Hartford FundsForNo report
InvescoAgainst, against managementFor
J.P. MorganForFor
Jackson National fundsForFor
Janus HendersonForFor
John Hancock and ManulifeForFor
Lincoln FinancialForFor
MassMutualForNo report
MFSForFor
Morgan Stanley, Eaton Vance and CalvertForFor
NationwideForFor
Natixis and Loomis SaylesForNo report
Neuberger BermanForNo report
Northern Trust and FlexSharesForFor
Nuveen and TIAAForFor
Pacific Life fundsForFor
PGIM and PrudentialForFor
PrincipalForFor
ProShares and ProFundsForFor
Russell InvestmentsForFor
SEIForFor
State Street and SPDRForFor
T. Rowe PriceForFor
ThriventForFor
TransamericaForFor
VanguardForFor
Victory CapitalForFor
VirtusForFor
VoyaForFor
WisdomTreeForFor

Questions

How many filers reported votes at the Catalyst Pharmaceuticals, Inc. meeting?
387 Form N-PX filers reported votes at the meeting of 22 Aug 2023. On say-on-pay, 28 of 366 filers that marked the item voted against management (7.7%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Catalyst Pharmaceuticals, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Catalyst Pharmaceuticals, Inc. with a meeting date within three days of 22 Aug 2023. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .